A detailed history of Silver Lake Advisory, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Silver Lake Advisory, LLC holds 55,971 shares of ABBV stock, worth $9.36 Million. This represents 2.47% of its overall portfolio holdings.

Number of Shares
55,971
Previous 55,124 1.54%
Holding current value
$9.36 Million
Previous $8.54 Million 19.3%
% of portfolio
2.47%
Previous 4.79%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$159.82 - $182.1 $135,367 - $154,238
847 Added 1.54%
55,971 $10.2 Million
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $196,492 - $221,297
1,428 Added 2.66%
55,124 $8.54 Million
Q3 2023

Oct 25, 2023

BUY
$133.59 - $154.65 $84,295 - $97,584
631 Added 1.19%
53,696 $8 Million
Q2 2023

Jul 24, 2023

BUY
$132.51 - $164.9 $35,115 - $43,698
265 Added 0.5%
53,065 $7.15 Million
Q1 2023

Apr 25, 2023

BUY
$144.61 - $166.54 $71,292 - $82,104
493 Added 0.94%
52,800 $8.41 Million
Q4 2022

Jan 30, 2023

BUY
$138.31 - $165.87 $56,983 - $68,338
412 Added 0.79%
52,307 $8.46 Million
Q3 2022

Oct 20, 2022

BUY
$134.21 - $153.93 $48,181 - $55,260
359 Added 0.7%
51,895 $6.97 Million
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $33,579 - $42,690
244 Added 0.48%
51,536 $7.89 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $1.93 Million - $2.4 Million
-14,633 Reduced 22.2%
51,292 $8.32 Million
Q4 2021

Jan 13, 2022

SELL
$107.43 - $135.93 $167,805 - $212,322
-1,562 Reduced 2.31%
65,925 $8.93 Million
Q3 2021

Oct 28, 2021

BUY
$106.4 - $120.78 $83,311 - $94,570
783 Added 1.17%
67,487 $7.28 Million
Q2 2021

Aug 04, 2021

SELL
$105.21 - $117.21 $59,969 - $66,809
-570 Reduced 0.85%
66,704 $7.75 Million
Q1 2021

Apr 27, 2021

BUY
$102.3 - $112.62 $85,215 - $93,812
833 Added 1.25%
67,274 $7.28 Million
Q4 2020

Feb 04, 2021

BUY
$80.49 - $108.67 $5.34 Million - $7.21 Million
66,334 Added 61994.39%
66,441 $7.12 Million
Q4 2020

Feb 03, 2021

SELL
$80.49 - $108.67 $5.37 Million - $7.25 Million
-66,679 Reduced 99.84%
107 $7.12 Million
Q3 2020

Nov 04, 2020

SELL
$85.91 - $100.83 $98,023 - $115,047
-1,141 Reduced 1.68%
66,786 $5.85 Million
Q2 2020

Jul 28, 2020

BUY
$73.37 - $98.18 $47,470 - $63,522
647 Added 0.96%
67,927 $6.67 Million
Q1 2020

Apr 22, 2020

BUY
$64.5 - $97.79 $2.9 Million - $4.4 Million
44,962 Added 201.46%
67,280 $5.13 Million
Q1 2020

Apr 21, 2020

SELL
$64.5 - $97.79 $2.88 Million - $4.36 Million
-44,579 Reduced 66.64%
22,318 $5.13 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $102,352 - $128,064
1,419 Added 2.17%
66,897 $5.92 Million
Q3 2019

Oct 21, 2019

BUY
$62.98 - $75.72 $2.58 Million - $3.1 Million
40,998 Added 167.48%
65,478 $4.96 Million
Q2 2019

Aug 01, 2019

BUY
$65.7 - $83.98 $17,936 - $22,926
273 Added 1.13%
24,480 $1.78 Million
Q1 2019

Apr 18, 2019

SELL
$77.14 - $90.79 $149 Million - $175 Million
-1,926,599 Reduced 98.76%
24,207 $1.95 Million
Q1 2019

Apr 17, 2019

BUY
$77.14 - $90.79 $149 Million - $175 Million
1,925,367 Added 7568.56%
1,950,806 $1.95 Million
Q4 2018

Feb 05, 2019

SELL
$77.85 - $96.01 $45,386 - $55,973
-583 Reduced 2.24%
25,439 $2.35 Million
Q3 2018

Oct 16, 2018

BUY
$88.91 - $98.84 $16,359 - $18,186
184 Added 0.71%
26,022 $2.46 Million
Q3 2018

Oct 15, 2018

SELL
$88.91 - $98.84 $25,517 - $28,367
-287 Reduced 1.1%
25,838 $2.3 Million
Q2 2018

Jul 16, 2018

BUY
$89.78 - $106.23 $28,819 - $34,099
321 Added 1.24%
26,125 $1.89 Million
Q1 2018

Apr 17, 2018

BUY
$92.01 - $123.21 $10,581 - $14,169
115 Added 0.45%
25,804 $2.44 Million
Q4 2017

Jan 31, 2018

SELL
$89.56 - $98.21 $13,344 - $14,633
-149 Reduced 0.58%
25,689 $2.48 Million
Q3 2017

Oct 17, 2017

BUY
$69.85 - $89.22 $1.8 Million - $2.31 Million
25,838
25,838 $2.3 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $296B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Silver Lake Advisory, LLC Portfolio

Follow Silver Lake Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silver Lake Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silver Lake Advisory, LLC with notifications on news.